Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 19, 2021

Vitamin D retesting by general practitioners: a factor and cost analysis

  • Helena Scully ORCID logo EMAIL logo , Eamon Laird , Martin Healy , Vivion Crowley , James Bernard Walsh and Kevin McCarroll

Abstract

Objectives

Vitamin D testing by Primary Care doctors is increasing, placing greater workloads on healthcare systems. There is little data though on vitamin D retesting in Ireland. This study aims to investigate the factors associated with vitamin D retesting by Irish General Practitioners (GPs) and examine the resulting costs.

Methods

This is a retrospective analysis over 5 years (2014–2018) of GP requested 25-hydroxyvitamin D (25(OH)D) results in 36,458 patients at a major city hospital in Dublin, Ireland. Those with one test were compared with individuals who were retested and samples categorised to determine changes in status between tests.

Results

Nearly one in four patients (n=8,305) were retested. Positive predictors of retesting were female (p<0.001), age (60–69 years, p<0.001), location (Co. Kildare, p<0.001) and initial deficiency (<30 nmol/L, p<0.001) or insufficiency (30–49.9 nmol/L, p<0.001). Vitamin D status improved on retesting, with deficiency halving on first retest (9 vs. 18%, p<0.001) and dropping to 6% on further retests. About 12.2% of retests were done within 3 months and 29% had ≥2 retests within 1 year. 57% of retests were in those initially vitamin D replete (>50 nmol/L). The annual cost of inappropriate testing was €61,976.

Conclusions

One in four patients were retested and this varied by age, gender and patient location. Over 10% of retests were inappropriately early (<3 months), a third too frequent and over half were in replete individuals incurring significant costs. Clear guidance for GPs on minimum retesting intervals is needed, as well as laboratory ordering systems to limit requests using pre-defined criteria.


Corresponding author: Helena Scully, Mercers Institute for Research on Ageing, St James’s Hospital, Dublin 8, Ireland, E-mail:

Funding source: Mercers’ Institute

Funding source: Glanbia PLC

  1. Research funding: This research is partially funded by Mercers’ Institute and Glanbia PLC. Glanbia has no role in study design, data collection and analysis, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

  2. Author contributions: Conceptualization, EL, JBW and KMcC; Data curation, MH and VC; Formal analysis, HS, EL, KMcC, MH and VC; Funding acquisition, EL, JBW and KMcC; Investigation, HS; Methodology, HS; Project administration, HS; Supervision, KMcC; Writing – original draft, HS; Writing – review & editing, HS, EL, MH, JBW, VC and KMcC. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not Applicable.

  5. Ethical approval: St James’s Hospital/Tallaght University Hospital (SJH/TUH) joint ethics committee granted ethical approval for this study (Ref: 5475) which was conducted according to the guidelines laid down in the Declaration of Helsinki 1964.

References

1. Scientific Advisory Committee on Nutrition. SACN vitamin D and health report. London, UK: Public Health England; 2016.Search in Google Scholar

2. Gaksch, M, Jorde, R, Grimnes, G, Joakimsen, R, Schirmer, H, Wilsgaard, T, et al.. Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PloS One 2017;12:e0170791. https://doi.org/10.1371/journal.pone.0170791.Search in Google Scholar

3. de Abreu, DF, Eyles, D, Feron, F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009;34:S265–77. https://doi.org/10.1016/j.psyneuen.2009.05.023.Search in Google Scholar

4. Song, Y, Wang, L, Pittas, AG, Del Gobbo, LC, Zhang, C, Manson, JE, et al.. Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes: a meta-analysis of prospective studies. Am Diabetes Assoc 2013;36:1422–8. https://doi.org/10.2337/dc12-0962.Search in Google Scholar

5. Laird, E, McNulty, H, Ward, M, Hoey, L, McSorley, E, Wallace, J, et al.. Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab 2014;99:1807–15. https://doi.org/10.1210/jc.2013-3507.Search in Google Scholar

6. Laird, E, Kenny, RA. Vitamin D deficiency in Ireland–implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA). Ir Med J 2019. https://www.doi.org/10.38018/TildaRe.2020-05.10.38018/TildaRe.2020-05Search in Google Scholar

7. Briggs, R, McCarroll, K, O’Halloran, A, Healy, M, Kenny, RA, Laird, E. Vitamin D deficiency is associated with an increased likelihood of incident depression in community-dwelling older adults. J Am Med Dir Assoc 2019;20:517–23. https://doi.org/10.1016/j.jamda.2018.10.006.Search in Google Scholar

8. Scully, H, Laird, E, Healy, M, Walsh, JB, Crowley, V, McCarroll, K. Geomapping vitamin D status in a large city and surrounding population—exploring the impact of location and demographics. Nutrients 2020;12:2663. https://doi.org/10.3390/nu12092663.Search in Google Scholar

9. Laird, E, O’Halloran, AM, Carey, D, Healy, M, O’Connor, D, Moore, P, et al.. The prevalence of vitamin D deficiency and the determinants of 25 (OH) D concentration in older Irish adults: data from The Irish Longitudinal Study on Ageing (TILDA). J Gerontol A-Biol. 2018;73:519–25. https://doi.org/10.1093/gerona/glx168.Search in Google Scholar

10. Cashman, KD, Muldowney, S, McNulty, B, Nugent, A, FitzGerald, AP, Kiely, M, et al.. Vitamin D status of Irish adults: findings from the National Adult Nutrition Survey. Br J Nutr 2013;109:1248–56. https://doi.org/10.1017/s0007114512003212.Search in Google Scholar

11. McCarroll, K, Beirne, A, Casey, M, McNulty, H, Ward, M, Hoey, L, et al.. Determinants of 25-hydroxyvitamin D in older Irish adults. Age Ageing 2015;44:847–53. https://doi.org/10.1093/ageing/afv090.Search in Google Scholar

12. McKenna, MJ, Murray, B, Crowley, RK, Twomey, PJ, Kilbane, MT. Laboratory trend in vitamin D status in Ireland: dual concerns about low and high 25OHD. J Steroid Biochem Mol Biol 2019;186:105–9. https://doi.org/10.1016/j.jsbmb.2018.10.001.Search in Google Scholar

13. Sattar, N, Welsh, P, Panarelli, M, Forouhi, NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012;379:95. https://doi.org/10.1016/s0140-6736(11)61816-3.Search in Google Scholar

14. Crowe, FL, Jolly, K, MacArthur, C, Manaseki-Holland, S, Gittoes, N, Hewison, M, et al.. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005–2015. BMJ Open 2019;9:e028355. https://doi.org/10.1136/bmjopen-2018-028355.Search in Google Scholar

15. Rodd, C, Sokoro, A, Lix, LM, Thorlacius, L, Moffatt, M, Slater, J, et al.. Increased rates of 25-hydroxy vitamin D testing: dissecting a modern epidemic. Clin Biochem 2018;59:56–61. https://doi.org/10.1016/j.clinbiochem.2018.07.005.Search in Google Scholar

16. Caillet, P, Goyer-Joos, A, Viprey, M, Schott, A-M. Increase of vitamin D assays prescriptions and associated factors: a population-based cohort study. Sci Rep 2017;7:1–7. https://doi.org/10.1038/s41598-017-10263-8.Search in Google Scholar

17. Bilinski, K, Boyages, S. Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data. BMJ Open 2013;3. https://doi.org/10.1136/bmjopen-2013-002955.Search in Google Scholar

18. Munk, JK, Bathum, L, Jørgensen, HL, Lind, BS. A compulsory pop-up form reduces the number of vitamin D requests from general practitioners by 25 percent. Scand J Prim Health Care 2020;38:308–14. https://doi.org/10.1080/02813432.2020.1794399.Search in Google Scholar

19. Murrin, S. Medicare payments for clinical diagnostic laboratory tests in 2017: Year 4 of baseline data. Washington, USA: U.S. Department of Health and Human Services, Office of the Inspector General; 2018. Available from: https://oig.hhs.gov/oei/reports/oei-09-18-00410.pdf.Search in Google Scholar

20. Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, Gordon, CM, Hanley, DA, Heaney, RP, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30. https://doi.org/10.1210/jc.2011-0385.Search in Google Scholar

21. Francis, R, Aspray, T, Fraser, W, McDonald, H, Patel, S, Mavroeidi, A, et al.. Vitamin D and bone health: a practical clinical guideline for patient management. Bath, UK: Royal Osteoporosis Society; 2018. Available from: https://www.endocrinology.org/media/3593/nos_vitamin_d_and_bone_-health_in_adults_web.pdf.Search in Google Scholar

22. Harrison, M, Davidson, J, Lu, Z, Morris, H, Schneider, H, Glendenning, P. Use and interpretation of vitamin D testing. Sydney, Australia: The Royal College of Pathologists of Australia; 2013. Available from: https://www.rcpa.edu.au/Library/College-Policies/Position-Statements/Use-and-Interpretation-of-Vitamin-D-Testing.Search in Google Scholar

23. Jenkins, S. SCBMDN Guidance on appropriate testing for 25-OH Vitamin D. Edinburgh, Scotland: Scottish Clinical Biochemistry Network; 2018. Available from: https://www.clinicalbiochemistry.scot.nhs.uk/wp-content/uploads/2018/09/2018-08-09-SCBMDN-Vit-D-Guideline-v1.pdf.Search in Google Scholar

24. Woodford, HJ, Barrett, S, Pattman, S. Vitamin D: too much testing and treating? Clin Med 2018;18:196. https://doi.org/10.7861/clinmedicine.18-3-196.Search in Google Scholar

25. Hofstede, H, Van Der Burg, H, Mulder, B, Bohnen, A, Bindels, P, de Wit, N, et al.. Reducing unnecessary vitamin testing in general practice: barriers and facilitators according to general practitioners and patients. BMJ Open 2019;9:e029760. https://doi.org/10.1136/bmjopen-2019-029760.Search in Google Scholar

26. Morgen, EK, Naugler, C. Inappropriate repeats of six common tests in a Canadian city: a population cohort study within a laboratory informatics framework. Am J Clin Pathol 2015;144:704–12. https://doi.org/10.1309/ajcpyxdaus2f8xjy.Search in Google Scholar

27. Delos Reyes, J, Smyth, A, Griffin, D, O’Shea, P, O’Keeffe, S, Mulkerrin, E. Vitamin D deficiency and insufficiency prevalence in the west of Ireland-A retrospective study. J Nutr Health Aging 2017;21:1107–10. https://doi.org/10.1007/s12603-017-0889-0.Search in Google Scholar

28. Boran, G, Seheult, J. Laboratory testing for vitamin D deficiency. Dublin, Ireland: National Clinical Programme for Pathology, Health Service Executive; 2018. Available from: https://www.hse.ie/eng/about/who/cspd/ncps/pathology/resources/lab-testing-for-vit-d-deficiency11.pdf.Search in Google Scholar

29. Institute of Medicine (IOM). Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press.; 2011.Search in Google Scholar

30. Zhao, S, Gardner, K, Taylor, W, Marks, E, Goodson, N. Vitamin D assessment in primary care: changing patterns of testing. Lond J Prim Care 2015;7:15–22. https://doi.org/10.1080/17571472.2015.11493430.Search in Google Scholar

31. Essig, S, Merlo, C, Reich, O, Trottmann, M. Potentially inappropriate testing for vitamin D deficiency: a cross-sectional study in Switzerland. BMC Health Serv Res 2020;20:1–8. https://doi.org/10.1186/s12913-020-05956-2.Search in Google Scholar

32. Wang, Y, Hunt, K, Nazareth, I, Freemantle, N, Petersen, I. Do men consult less than women? An analysis of routinely collected UK general practice data. BMJ Open 2013;3:e003320. https://doi.org/10.1136/bmjopen-2013-003320.Search in Google Scholar

33. Peklar, J, Henman, MC, Richardson, K, Kos, M, Kenny, RA. Food supplement use in the community dwelling population aged 50 and over in the Republic of Ireland. Compl Ther Med 2013;21:333–41. https://doi.org/10.1016/j.ctim.2013.06.004.Search in Google Scholar

34. Aspray, TJ, Bowring, C, Fraser, W, Gittoes, N, Javaid, MK, Macdonald, H, et al.. National Osteoporosis Society vitamin D guideline summary. Age Ageing 2014;43:592–5. https://doi.org/10.1093/ageing/afu093.Search in Google Scholar

35. McKenna, MJ, Murray, BF. Vitamin D dose response is underestimated by Endocrine Society’s Clinical Practice Guideline. Endocr Connect 2013;2:87–95. https://doi.org/10.1530/ec-13-0008.Search in Google Scholar

36. Díez, A, Carbonell, C, Calaf, J, Caloto, MT, Nocea, G. Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain. Menopause 2012;19:89–95. https://doi.org/10.1097/gme.0b013e318223bd6b.Search in Google Scholar

37. Dunlop, S, Coyte, PC, McIsaac, W. Socio-economic status and the utilisation of physicians’ services: results from the Canadian National Population Health Survey. Soc Sci Med 2000;51:123–33. https://doi.org/10.1016/s0277-9536(99)00424-4.Search in Google Scholar

38. Health in Ireland - key trends 2019. Dublin, Ireland: Department of Health: Government of Ireland; 2020.Search in Google Scholar

39. Kotta, S, Gadhvi, D, Jakeways, N, Saeed, M, Sohanpal, R, Hull, S, et al.. “Test me and treat me”—attitudes to vitamin D deficiency and supplementation: a qualitative study. BMJ Open 2015;5:e007401. https://doi.org/10.1136/bmjopen-2014-007401.Search in Google Scholar

40. Chami, N, Simons, JE, Sweetman, A, Don-Wauchope, AC. Rates of inappropriate laboratory test utilization in Ontario. Clin Biochem 2017;50:822–7. https://doi.org/10.1016/j.clinbiochem.2017.05.004.Search in Google Scholar

41. Pilz, S, Zittermann, A, Trummer, C, Theiler-Schwetz, V, Lerchbaum, E, Keppel, MH, et al.. Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect 2019;8:R27–43. https://doi.org/10.1530/ec-18-0432.Search in Google Scholar

42. Hendrickson, CD, McLemore, MF, Dahir, KM, Just, S, Shajani-Yi, Z, LeGrand, J, et al.. Is the climb worth the view? The savings/alert Ratio for reducing vitamin D testing. Appl Clin Inf 2020;11:160–5. https://doi.org/10.1055/s-0040-1701678.Search in Google Scholar

43. Felcher, AH, Gold, R, Mosen, DM, Stoneburner, AB. Decrease in unnecessary vitamin D testing using clinical decision support tools: making it harder to do the wrong thing. J Am Med Inf 2017;24:776–80. https://doi.org/10.1093/jamia/ocw182.Search in Google Scholar

44. Ferrari, R, Prosser, C. Testing vitamin D levels and choosing wisely. JAMA Intern Med 2016;176:1019–20. https://doi.org/10.1001/jamainternmed.2016.1929.Search in Google Scholar

45. Granado-Lorencio, F, Blanco-Navarro, I, Pérez-Sacristán, B. Criteria of adequacy for vitamin D testing and prevalence of deficiency in clinical practice. Clin Chem Lab 2016;54:791–8. https://doi.org/10.1515/cclm-2015-0781.Search in Google Scholar

46. Pelloso, M, Basso, D, Padoan, A, Fogar, P, Plebani, M. Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting. J Clin Pathol 2016;69:777–83. https://doi.org/10.1136/jclinpath-2015-203447.Search in Google Scholar

47. Wilson, LF, Xu, Z, Mishra, GD, Dobson, AJ, Doust, J. Did changes to recommended testing criteria affect the rate of vitamin D testing among Australian women. Arch Osteoporos 2020;15:1–10. https://doi.org/10.1007/s11657-020-00840-2.Search in Google Scholar

48. Jääskeläinen, T, Itkonen, ST, Lundqvist, A, Erkkola, M, Koskela, T, Lakkala, K, et al.. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am J Clin Nutr 2017;105:1512–20. https://doi.org/10.3945/ajcn.116.151415.Search in Google Scholar

49. Aguiar, M, Andronis, L, Pallan, M, Högler, W, Frew, E. The economic case for prevention of population vitamin D deficiency: a modelling study using data from England and Wales. Eur J Clin Nutr 2020;74:825–33. https://doi.org/10.1038/s41430-019-0486-x.Search in Google Scholar

50. McCartney, DM, O’Shea, PM, Faul, JL, Healy, MJ, Byrne, G, Griffin, TP, et al.. Vitamin D and SARS-CoV-2 infection—evolution of evidence supporting clinical practice and policy development. Ir J Med Sci 2020:1–13. https://doi.org/10.1007/s11845-020-02427-9.Search in Google Scholar

51. Zgaga, L, Laird, E, Healy, M. 25-Hydroxyvitamin D measurement in human hair: results from a proof-of-concept study. Nutrients 2019;11:423. https://doi.org/10.3390/nu11020423.Search in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2021-0607).


Received: 2021-05-21
Accepted: 2021-07-01
Published Online: 2021-07-19
Published in Print: 2021-10-26

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2021-0607/html
Scroll to top button